Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market – Novel Agents Transforming Platelet Disorder Care
Market Overview The idiopathic thrombocytopenic purpura therapeutics market is expanding as new treatment options improve care for patients with low platelet counts. ITP is an autoimmune disorder that can cause bruising, bleeding, and fatigue. Therapies include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and emerging targeted agents. The Idiopathic Thrombocytopenic...
0 Comments 0 Shares 2 Views 0 Reviews
Moundo https://moundo.social